Post by
AviseAnalyticson Jun 17, 2022 8:21am
$GERN Geron Corporation (NASDAQ: GERN) is a late-stage clinical biotechnology company developing a first-in-class telomerase inhibitor, imetelstat, intended to treat hematologic malignancies. A lot
...more